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and 14 weeks. Sodium intake was assessed using 24-hour urinary collec-
tions. Intervention data were analysed using one-way ANCOVA.
Results: Thirty-nine and thirty-four subjects completed the VD and HD
respectively. Sodium intake remained unchanged in the HD (mean change
-0.04 mmol/L; 95%CI: -18.4, 18.3; p ¼ 0.99), while the VD saw a mean 35.4
mmol/L reduction (95%CI: 20.5-50.3; p < 0.001) with the intervention. IL-6
decreased over time by 1.47 pg/mL (95%CI: 1.21-1.78; p < 0.001) and 1.35
pg/mL (95%CI: 1.15-1.59; p < 0.001) for the VD and HD respectively.
However when diet groups were examined there was no association be-
tween sodium intake and IL-6 (p ¼ 0.52).
Conclusions: The inﬂammation status of individuals at risk of heart dis-
ease, as measured using IL-6, did change over time but the effect was not
driven by sodium intake in this cohort.
Funding source(s): Meat and Livestock Australia.
EFFECTS OF INCREASED POTASSIUM AND SODIUM ON ENDOTHELIAL
AND VASCULAR FUNCTION
N. Blanch 1, K.S. Petersen 1, P.M. Clifton 1, J.B. Keogh 1. 1 School of Pharmacy
and Medical Science, University of South Australia, Adelaide, Australia
E-mail: natalie.blanch@mymail.unisa.edu.au (N. Blanch)
Background/Aims: Increased potassium intake has been related to
improved endothelial function. High sodium intake is known to impair
endothelial function. The effect of increasing potassium in the presence of
high dietary sodium is not known. The aim was to determine the effect of
increased potassium and increased sodium on postprandial endothelial
function, as assessed by ﬂow mediated dilatation (FMD).
Methods: Thirty nine healthy, normotensive volunteers (mean ± SD age 37
± 15 years and BMI 23.0 ± 2.8 kg/m2) received a meal with 3.1 mmol
potassium and 65 mmol sodium (LKHNa), a meal with 38 mmol potassium
and 65 mmol sodium (HKHNa) and a control meal (LKLNa) with 5.5 mmol
sodium and 3.1 mmol potassium on three separate occasions in a ran-
domized order. FMD, pulse wave velocity (PWV) and blood pressure (BP)
were measured while participants were fasting and at 30, 60, 90 and 120
minutes after the meal. Repeated-measures ANOVAwas used to assess the
effects of the meal type on the dependent variables over time.
Results: The addition of potassium (HKHNa) signiﬁcantly attenuated the
post meal decrease in FMD when compared to the high sodium meal and
control meals (p < 0.05). FMD was signiﬁcantly lower following the LKHNa
meal when compared to the HKHNa meal at 30 minutes (p < 0.05). There
was no signiﬁcant differences in PWV or BP between treatments.
Conclusions: The addition of potassium to a high sodium meal attenuates
thepostmeal reduction inendothelial functionasassessedby FMD. Increases
in sodium and potassium do not affect PWV or BP in the postprandial state.
Funding source(s): The University of South Australia.
UPDATING AN EXISTING REVIEW
D. Mackerras 1, C. Larter 1. 1 Food Standards Australia New Zealand, Canberra,
ACT, Australia
E-mail: dorothy.mackerras@foodstandards.gov.au (D. Mackerras)
Background/Aims: A systematic review is ‘time-stamped’ to the date of
the literature search. A quantitative result (i.e. meta-analysis) might
change when relevant new studies are published and the review is
updated. We describe three ways of examining whether new data alter the
conclusion of He et al (2013) that lowering sodium intake reduces blood
pressure (-4.18 mmHg, 95%CI: -5.18,-3.18 random effects analysis).
Methods: One new paper was found when the literature search was repli-
cated for theperiodDecember2012 toAugust 2013. Its impacton theexisting
result was examined using: shorthand estimation, complete re-analysis and
update by combining the previous overall effect with the additional result.
Results: The new study had a mean reduction in blood pressure larger (-12
mmHg, p< 0.01) than the existingmeta-analysis result. Therefore, this could
not reduce the size of the existing result. This might be a sufﬁcient assess-
ment in certain situations. Complete randomeffects re-analysis yielded -4.32
mmHg (95%CI: -5.33, -3.31). However combining the new results with the
previous overall result yielded -7.45 mmHg (95%CI: -15.01, 0.11) or -4.37
mmHg (95%CI: -5.36, -3.39) in a randomorﬁxed effects analysis respectively.Conclusions: The variation in results seen would not be observed in all
datasets. Short-cut methods can be useful in certain circumstances. Care
needs to be taken when interpreting the results of any analysis.
Funding source(s): N/A.Concurrent session 8: dietary composition and
metabolic outcomes
SATURATED FAT INTAKE, STATIN THERAPY AND ATHEROSCLEROTIC
VASCULAR DISEASE: A PROSPECTIVE COHORT STUDY
L. Blekkenhorst 1, R. Prince 1, J. Hodgson 1, W. Lim 1, A. Devine 2, J.
Lewis 1. 1 School of Medicine and Pharmacology, University of Western
Australia, WA, Australia; 2 School of Exercise and Health Science, Edith
Cowan University, WA, Australia
E-mail: lauren.blekkenhorst@research.uwa.edu.au (L. Blekkenhorst)
Background/Aims: The relationship between saturated fat (SFA), statin
therapy and atherosclerotic vascular disease (ASVD) remains uncertain,
particularly in the elderly population. The aim of this study was to
investigate the association of SFA intake, statin therapy and risk of ASVD
death in a population of elderly women.
Methods: A prospective cohort study of 1,469 women living in Perth,
Western Australia, mean age 75.2 (SD 2.7) years, had SFA intake assessed
using a validated food frequency questionnaire. Statin use was determined
from patient report veriﬁed by medical record data. Total ASVD deaths
were retrieved from the Western Australian Data Linkage System. HR was
tested using Cox regression analysis.
Results: At baseline mean (SD) SFA intake was 25 (11) g/day and 268 (18%)
participants were taking statin medication. Over 10 years, 134 participants
died from ASVD-related causes. In the highest compared with the lowest
quartile of SFA intake, the risk of ASVD death was higher in the total cohort
(HR ¼ 3.04, p ¼ 0.002) and the statin non-user subset (HR ¼ 3.55, p ¼
0.001), but not in the statin user subset (HR ¼ 1.05, p ¼ 0.962).
Conclusions: High SFA intake was associated with increased risk of 10-
year ASVD death in elderly women. The risk was most evident in partici-
pants with SFA intake > 31 g/day and not taking statin medication. These
data support current practice to lower SFA intake in low risk individuals
and to continue statin therapy in high risk individuals.
Funding source(s): Healthway and NHMRC.
DIETARY INTAKE AND BEHAVIOURS IN PEOPLE WITH SEVERE MENTAL
ILLNESS ACROSS FOUR COUNTRIES: COMPARISON WITH A NORMATIVE
SAMPLE
N. Parletta 1, D. Zarnowiecki 1, Y. Aljeesh 2, B.T. Baune 3. 1 School of
Population Health, University of South Australia, Australia; 2 Faculty of
Nursing, Islamic University, Gaza, Palestinian Authority; 3Department of
Psychiatry, University of Adelaide, Australia
E-mail: natalie.parletta@unisa.edu.au (N. Parletta)
Background/Aims: Physical health is inextricably linked with mental
health; people with severe mental illness (SMI) have poor physical health,
high mortality and cardiovascular diseases. We investigated dietary intake
and behaviours in people with SMI and compared with a normative sample.
Methods: Demographic and health behaviour data were collected from
697 people with SMI (aged 17-69 years) in Germany (n¼ 387), Middle East
(n ¼ 200), London (n ¼ 67) and Australia (n ¼ 43). Data were analysed by
one-sample t-tests with 666 people with substance abuse disorder (n ¼
224), schizophrenia (n ¼ 158), mood disorders (n ¼ 227) and somatoform
disorders (n ¼ 63). The General health Behaviour Questionnaire investi-
gated dietary intake of healthy food/drinks and ‘traditional’ (unhealthy)
food, regularity of meals, snacking, eating out, emotional eating and
knowledge regarding the impact of diet on health. The normative sample
was derived from a German population (n ¼ 495).
Results: The whole sample had signiﬁcantly lower intake of healthy food/
drinks and higher intake of ‘traditional’ (unhealthy) food (both p <
0.001); these remained consistent across the four subgroups. They re-
ported higher snacking, less regular meals, eating out , eating more when
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regarding the effect of diet on health (all p < 0.001; consistent across
subgroups).
Conclusions: Diet and nutrition education present an important target for
primary care of people with SMI. Targeting at-risk populations also pre-
sents an opportunity for prevention. Although research has identiﬁed the
contribution of individual nutrients to mental health, further research
needs to elucidate the role of whole diet and nutrition and mental illness.
Funding source(s): N/A.
MACRO AND MICRONUTRIENT DIFFERENCES OF ADdLIBITUM
PALAEOLITHIC VS AUSTRALIAN GUIDE TO HEALTHY EATING DIETS
A. Genoni 1, A. Devine 1, J. Lo 2, P. Lyons-Wall 1. 1 School of Exercise and
Health Sciences, Perth, WA, Australia; 2 School of Engineering, Edith Cowan
University, Perth, WA, Australia
E-mail: agenoni@our.ecu.edu.au (A. Genoni)
Background/Aims: To investigate the differences in the macronutrient
composition between the palaeolithic and AGHE Diet.
Methods: Thirty nine healthy women (mean ± SD age 47 ± 13 years, BMI
27 ± 4 kg/m2) were randomised to either the palaeolithic (n¼ 22) or AGHE
diet (n ¼ 17) for 4-weeks. A 3-day weighed food record (WFR) was
collected pre- and post-intervention. WFR were analysed using Food-
Works (AUSNUT2007, Xyris Software, QLD, 2012). Within group analysis
was performed using paired t-tests, between group analysis was con-
ducted using Mann-Whitney and independent t-tests.
Results: The palaeolithic group had a lower intake of carbohydrate (28 ±
8% vs 41 ± 9% of energy, p < 0.05), and higher intake of fat (40 ± 10% vs 33 ±
7%, p < 0.05) and protein (27 ± 7% vs 22 ± 6%, p < 0.05) compared to AGHE.
Within group analyses showed reductions in saturated fat intake in both
groups (p < 0.05) but no change to dietary ﬁbre or total sugars. Within the
palaeolithic group, there were signiﬁcant reductions in energy, thiamin,
riboﬂavin, sodium and calcium and increases in vitamins C, E and b-
carotene (all p < 0.05).
Conclusions: Despite the reduction in carbohydrates due to the removal of
whole grain cereals and dairy, ﬁbre intake was not impacted in the
palaeolithic group. However, signiﬁcant reductions in B vitamins and
calcium were seen. Further research to explore the health implications
related to long-term palaeolithic dietary patterns are recommended.
Funding source(s): N/A.
LONG-TERM EFFECTS OF VERY LOW- AND HIGH-CARBOHYDRATE
WEIGHT LOSS DIETS ON MOOD RESPONSE IN OBESE ADULTS WITH
TYPE 2 DIABETES
G.D. Brinkworth 1, N.D. Luscombe-Marsh 1, C.H. Thompson 2, M.
Noakes 1, J.D. Buckley 3, G. Wittert 2, C.J. Wilson 4. 1CSIRO Food and
Nutrition, SA, Australia; 2Department of Medicine, University of South
Australia, SA, Australia; 3Nutritional Physiology Research Centre, University
of South Australia, SA, Australia; 4 School of Medicine, Flinders University,
SA, Australia
E-mail: grant.brinkworth@csiro.au (G.D. Brinkworth)
Background/Aims: Very low carbohydrate, high fat (LC) diets are used for
T2DM management. Previous research has shown compared to a high
carbohydrate, low fat (HC) diet, a LC diet have less favourable effects on
mood state in obese patients without diabetes. However, effects in T2DM
at heightened risk of mood disturbance and depression remain unknown.
This study compared the effects of an energy-restricted LC diet and an
isocaloric HC diet on mood state over 12-months.
Methods: Subjects (n ¼ 115; mean ± SD age: 58 ± 7 years; BMI: 34.6 ± 4.3
kg/m2; HbA1c: 7.3 ± 1.1%) were randomly assigned to consume either a
hypocaloric (~6-7 MJ), planned isocaloric LC or HC diet, combined with
exercise (3 day/week) for 1-yr. Body weight and psychological mood state
measured by validated questionnaires - Proﬁle of Mood States (POMS), Beck
Depression Inventory (BDI) and Spielberger State-Trait Anxiety Inventory
(STAI) were assessed monthly. Data was analysed with mixed models.
Results: Overall weight loss was 9.5 ± 0.5 kg; no difference between
groups (p ¼ 0.91). Over the course of the study there were signiﬁcant
improvements in BDI and the POMS scores (total mood disturbance and 6subscales (anger-hostility, confusion-bewilderment, depression-dejection,
fatigue, vigor and tension-anxiety), p < 0.05 for time, effect size: 14-43%.
STAI remained largely unchanged (p ¼ 0.08 time). There was no diet effect
on the responses for any of the outcomes (p ¼ 0.22 time  diet).
Conclusions: Over 1 year both diets achieved substantial weight loss and
similar improvements in mood state and affect. This suggests either an LC
or HC diet when combined with exercise in a lifestyle modiﬁcation pro-
gram improve psychological wellbeing in T2DM.
Funding source(s): NHMRC.
RICE INTAKE IS INVERSELY RELATED TO CARDIOVASCULAR MORTALITY
AMONG CHINESE ADULTS
Z. Shi 1,2, S. Zhen 2, L. Qi 3, Y. Zhou 2, A. Taylor 1. 1Discipline of Medicine, The
University of Adelaide, SA, Australia; 2Department of Nutrition and
Foodborne Disease Prevention, Jiangsu Provincial Centre for Disease Control
and Prevention, Nanjing, China; 3Department of Nutrition, Harvard School
of Public Health, USA
E-mail: zumin.shi@adelaide.edu.au (Z. Shi)
Background/Aims: Few studies have assessed the association between
rice intake and mortality. The results from these studies are inconsistent.
We assessed whether rice intake was associated with CVD mortality,
cancer mortality and all-cause mortality in a Chinese population.
Methods: We prospectively studied 2,832 adults aged 20 years and above
with a mean follow up of 10 years. Rice intake was assessed by 3-day
weighed food record (WFR) in 2002. HRs and 95%CI were calculated by
competing risks regression (CVD and cancer mortality) and Cox propor-
tional hazards analysis (all-cause mortality). A meta-analysis on rice intake
and CVD mortality was conducted.
Results: We documented 184 deaths (70 CVD deaths and 63 cancer
deaths) during 27,741 person-years of follow-up. Rice intake was inversely
associated with CVDmortality. HRs for CVD mortality across tertiles of rice
intake was 1.00, 0.53 (95%CI: 0.25, 1.11), and 0.34 (95%CI: 0.13, 0.90), p for
trend 0.019. No association between rice intake and all-cause mortality
was found. There was a trend of increased risk of cancer mortality among
those with high intake of rice. In the meta-analysis which included three
prospective studies, a high rice intake tended to be associated with
reduced CVD mortality with pooled RR of 0.91 (95%CI: 0.76, 1.11).
Conclusions: Rice intake was inversely related to CVD mortality. There
was no association between rice intake and cancer- or all-cause mortality.
Funding source(s): N/A.
DIETARY PROTEIN AND THE METABOLIC SYNDROME: A RANDOMISED
CONTROLLED TRIAL
A.M. Hill 1, K.A. Harris-Jackson 2, M.A. Roussell 2, P.M. Kris-
Etherton 2. 1Nutritional Physiology Research Centre & School of Pharmacy
and Medical Sciences, University of South Australia, Australia; 2Department
of Nutritional Sciences, The Pennsylvania State University, USA
E-mail: alison.hill@unisa.edu.au (A.M. Hill)
Background/Aims: The aim of this study was to investigate the effect of
three diets controlled for saturated fat (SFA) and varying in type (animal vs.
plant) and amount (18% vs. 27%) of dietary protein on metabolic syndrome
(MetS) criteria.
Methods: Sixty-two overweight adults with MetS (age: 30 - 60 y; mean ±
SD BMI: 34.8 ± 0.5 kg/m2) consumed a healthy American diet (HAD) for 2
weeks before being randomised to either a modiﬁed-DASH diet rich in
plant protein (M-DASH: 18% protein, 2/3 plant sources, n ¼ ¼ 21); a
modiﬁed-DASH diet rich in animal protein (BOLD, 19% protein, 2/3 animal
sources, n ¼ 20); and a moderate protein diet (BOLD+: 27% protein, 2/3
animal sources, n ¼ 21). Diets were compared at three levels of energy
balance: controlled weight maintenance (WM), controlled weight loss
including exercise (WL), and free-living weight loss (FL). Differences in
MetS criteria, cholesterol, insulin and adiposity at the end of each phase
were tested using repeated measure ANCOVA (adjusted for age and sex).
Results: While no between groups differences were observed, there was a
signiﬁcantmain effect of phase (p< 0.01) for all endpoints except for insulin.
After the WM phase, all groups had a MetS prevalence of 80-90%, which
decreased signiﬁcantly to 50-60% after WL and maintained through FL.
